50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 6/10
Monitoring for AI engine activity
In the Engagemii AEO index
#28,845 of 469,219 in Healthcare for AI visibility
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. A Lupus or Lupus Nephritis Treatment Option just got measured.
6/10 means A Lupus or Lupus Nephritis Treatment Option is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.
Discover BENLYSTA (belimumab), an FDA-approved add-on therapy for active lupus or active lupus nephritis in people who are already taking other lupus medicines.
Industry: Healthcare
benlystademo.com2
Structured Data
8
Content Structure
6
Entity Clarity
6
E-E-A-T Signals
6
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for A Lupus or Lupus Nephritis Treatment Option.
Scored by Engagemii on July 15, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/benlystademo
Cite this score: Engagemii (2026). "AEO Score for A Lupus or Lupus Nephritis Treatment Option." Retrieved from https://engagemii.com/aeo/brands/benlystademo
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform